INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 24 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,211,000 | -5.8% | 7,735,000 | 0.0% | 0.01% | +16.7% |
| Q1 2022 | $7,651,000 | -3.6% | 7,735,000 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $7,935,000 | -1.0% | 7,735,000 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $8,016,000 | -1.2% | 7,735,000 | 0.0% | 0.01% | -14.3% |
| Q2 2021 | $8,110,000 | -81.0% | 7,735,000 | -79.8% | 0.01% | -82.9% |
| Q1 2021 | $42,707,000 | +13.7% | 38,240,000 | +17.0% | 0.04% | +10.8% |
| Q4 2020 | $37,556,000 | -12.7% | 32,690,000 | -16.6% | 0.04% | -26.0% |
| Q3 2020 | $43,009,000 | -25.2% | 39,175,000 | -33.6% | 0.05% | -24.2% |
| Q2 2020 | $57,477,000 | -6.4% | 59,035,000 | -18.0% | 0.07% | -19.5% |
| Q1 2020 | $61,376,000 | -16.4% | 71,995,000 | -5.8% | 0.08% | +22.4% |
| Q4 2019 | $73,397,000 | +57.1% | 76,455,000 | +38.2% | 0.07% | +45.7% |
| Q3 2019 | $46,727,000 | -36.9% | 55,330,000 | -27.5% | 0.05% | -33.3% |
| Q2 2019 | $74,087,000 | +5.1% | 76,340,000 | +5.7% | 0.07% | -1.4% |
| Q1 2019 | $70,525,000 | +213.4% | 72,190,000 | +127.2% | 0.07% | +180.0% |
| Q4 2018 | $22,502,000 | -14.9% | 31,780,000 | +2.5% | 0.02% | +4.2% |
| Q3 2018 | $26,454,000 | -40.3% | 31,005,000 | -35.6% | 0.02% | -44.2% |
| Q2 2018 | $44,317,000 | +47.1% | 48,175,000 | +42.2% | 0.04% | +48.3% |
| Q1 2018 | $30,121,000 | – | 33,875,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 2,974,000 | $2,536,000 | 1.90% |
| Mohican Financial Management, LLC | 500,000 | $422,000 | 1.47% |
| LINDEN ADVISORS LP | 51,146,000 | $43,311,000 | 1.32% |
| ZAZOVE ASSOCIATES LLC | 15,101,000 | $12,810,000 | 1.11% |
| DLD Asset Management, LP | 24,500,000 | $20,911,000 | 1.03% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 31,749,000 | $26,863,000 | 0.55% |
| Cheyne Capital Management (UK) LLP | 1,000,000 | $853,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 6,000,000 | $5,050,000 | 0.39% |
| Jabre Capital Partners S.A. | 1,100,000 | $943,000 | 0.31% |
| Orbimed Advisors | 26,500,000 | $22,611,000 | 0.27% |